HK1042649A1 - 嘧啶衍生物在預防和治療腦缺血中的應用 - Google Patents

嘧啶衍生物在預防和治療腦缺血中的應用

Info

Publication number
HK1042649A1
HK1042649A1 HK02104075.8A HK02104075A HK1042649A1 HK 1042649 A1 HK1042649 A1 HK 1042649A1 HK 02104075 A HK02104075 A HK 02104075A HK 1042649 A1 HK1042649 A1 HK 1042649A1
Authority
HK
Hong Kong
Prior art keywords
utilization
preventing
pyrimidine derivatives
treating cerebral
cerebral ischaemia
Prior art date
Application number
HK02104075.8A
Other languages
English (en)
Inventor
G‧斯坦納
K‧謝爾哈斯
W‧盧畢斯徹
U‧霍澤坎普
D‧斯塔克
M‧克諾普
L‧斯扎博
F‧伊梅林
F‧J‧加西亞-拉多納
H-P‧霍夫曼
L‧昂格
Original Assignee
巴斯福股份公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 巴斯福股份公司 filed Critical 巴斯福股份公司
Publication of HK1042649A1 publication Critical patent/HK1042649A1/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cardiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Urology & Nephrology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HK02104075.8A 1999-01-11 2002-05-31 嘧啶衍生物在預防和治療腦缺血中的應用 HK1042649A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19900545A DE19900545A1 (de) 1999-01-11 1999-01-11 Verwendung von Pyrimidinderivaten zur Prophylaxe und Therapie der zerebralen Ischämie
PCT/EP1999/010369 WO2000041695A1 (de) 1999-01-11 1999-12-24 Verwendung von pyrimidinderivaten zur prophylaxe und therapie der zerebralen ischämie

Publications (1)

Publication Number Publication Date
HK1042649A1 true HK1042649A1 (zh) 2002-08-23

Family

ID=7893836

Family Applications (1)

Application Number Title Priority Date Filing Date
HK02104075.8A HK1042649A1 (zh) 1999-01-11 2002-05-31 嘧啶衍生物在預防和治療腦缺血中的應用

Country Status (24)

Country Link
US (1) US6387912B1 (zh)
EP (1) EP1140096A1 (zh)
JP (1) JP2002534465A (zh)
KR (1) KR20010101442A (zh)
CN (1) CN1334732A (zh)
AU (1) AU2433800A (zh)
BG (1) BG105689A (zh)
BR (1) BR9916887A (zh)
CA (1) CA2359253A1 (zh)
CZ (2) CZ20012484A3 (zh)
DE (1) DE19900545A1 (zh)
HK (1) HK1042649A1 (zh)
HU (1) HUP0201149A3 (zh)
ID (1) ID30022A (zh)
IL (1) IL144146A0 (zh)
MX (1) MXPA01006967A (zh)
MY (1) MY133107A (zh)
NO (1) NO20013409L (zh)
NZ (1) NZ512767A (zh)
PL (1) PL348920A1 (zh)
SK (1) SK9692001A3 (zh)
TR (1) TR200102008T2 (zh)
WO (1) WO2000041695A1 (zh)
ZA (1) ZA200105475B (zh)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19900673A1 (de) 1999-01-11 2000-07-13 Basf Ag Verwendung von Bindungspartnern für 5-HT5-Rezeptoren zur Behandlung neurodegenerativer und neuropsychiatrischer Störungen
US6988199B2 (en) * 2000-07-07 2006-01-17 Message Secure Secure and reliable document delivery
JP4548882B2 (ja) * 1999-11-30 2010-09-22 興和創薬株式会社 ４，５，６，７−テトラヒドロチエノ〔２，３−ｃ〕ピリジン化合物
DE10031389A1 (de) * 2000-07-03 2002-01-17 Knoll Ag Pyrimidinderivate und ihre Verwendung zur Prophylaxe und Therapie der zerebralen Ischämie
DE10031390A1 (de) * 2000-07-03 2002-01-17 Knoll Ag Pyrimidinderivate und ihre Verwendung zur Prophylaxe und Therapie der zerebralen Ischämie
DE10259382A1 (de) * 2002-12-18 2004-07-01 Abbott Gmbh & Co. Kg 3-Substituierte 3,4-Dihydro-thieno[2,3-d]pyrimidin-4-on-Derivate, ihre Herstellung und Verwendung
CA2685753A1 (en) * 2007-05-09 2008-11-20 Neuromed Pharmaceuticals Ltd. Bicyclic pyrimidine derivatives as calcium channel blockers
JP5722781B2 (ja) * 2009-08-26 2015-05-27 武田薬品工業株式会社 縮合複素環誘導体およびその用途
WO2021257857A1 (en) 2020-06-19 2021-12-23 Incyte Corporation Naphthyridinone compounds as jak2 v617f inhibitors
WO2021257863A1 (en) 2020-06-19 2021-12-23 Incyte Corporation Pyrrolotriazine compounds as jak2 v617f inhibitors
WO2022006456A1 (en) 2020-07-02 2022-01-06 Incyte Corporation Tricyclic pyridone compounds as jak2 v617f inhibitors
KR20230057341A (ko) 2020-07-02 2023-04-28 인사이트 코포레이션 Jak2 v617f 억제제로서 삼환계 우레아 화합물
US11661422B2 (en) 2020-08-27 2023-05-30 Incyte Corporation Tricyclic urea compounds as JAK2 V617F inhibitors
US11919908B2 (en) 2020-12-21 2024-03-05 Incyte Corporation Substituted pyrrolo[2,3-d]pyrimidine compounds as JAK2 V617F inhibitors
AR125273A1 (es) 2021-02-25 2023-07-05 Incyte Corp Lactamas espirocíclicas como inhibidores de jak2 v617f

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4670560A (en) 1986-04-28 1987-06-02 Ortho Pharmaceutical Corporation Thienopyrimidine-2,4-dione derivatives and intermediates thereof
DE19636769A1 (de) 1996-09-10 1998-03-12 Basf Ag 3-Substituierte Pyrido [4',3':4,5]thieno[2,3-d]pyrimidin-Derivate, ihre Herstellung und Verwendung
DE19724979A1 (de) 1997-06-13 1998-12-17 Basf Ag 3-substituierte Pyrido [3,4,5]thieno[2,3-d]pyrimidin-Derivate, ihre Herstellung und Verwendung
DE19724980A1 (de) 1997-06-13 1998-12-17 Basf Ag 3-Substituierte 3,4-Dihydro-thieno[2,3-d]pyrimidin-Derivate, ihre Herstellung und Verwendung

Also Published As

Publication number Publication date
SK9692001A3 (en) 2002-05-09
CN1334732A (zh) 2002-02-06
NZ512767A (en) 2003-05-30
EP1140096A1 (de) 2001-10-10
HUP0201149A2 (hu) 2002-07-29
JP2002534465A (ja) 2002-10-15
US6387912B1 (en) 2002-05-14
IL144146A0 (en) 2002-05-23
CA2359253A1 (en) 2000-07-20
TR200102008T2 (tr) 2001-12-21
WO2000041695A1 (de) 2000-07-20
DE19900545A1 (de) 2000-07-13
BR9916887A (pt) 2001-11-20
BG105689A (en) 2002-02-28
MXPA01006967A (es) 2002-04-10
NO20013409D0 (no) 2001-07-10
HUP0201149A3 (en) 2003-07-28
AU2433800A (en) 2000-08-01
MY133107A (en) 2007-10-31
KR20010101442A (ko) 2001-11-14
PL348920A1 (en) 2002-06-17
ZA200105475B (en) 2002-10-03
CZ20012484A3 (cs) 2002-05-15
NO20013409L (no) 2001-08-30
CZ20012485A3 (cs) 2002-04-17
ID30022A (id) 2001-11-01

Similar Documents

Publication Publication Date Title
HUP0105154A3 (en) Use of anticonvulsant derivatives for treating cluster headaches
HUP0201149A3 (en) Utilization of pyrimidine derivatives for preventing and treating cerebral ischaemia
IL148496A0 (en) Therapeutic quinazoline derivatives
HUP0202477A3 (en) Use of phthalazine derivatives
HK1092804A1 (en) New quinazoline derivatives
HUP0201393A2 (en) Use of xenon for treating neurointoxications
PL339330A1 (en) Method of obtaining derivatives of quinazoline and novel intermediate compounds
HUP0105036A3 (en) Imidazo-quinolin derivatives for treating sexual disturbances
AU2001279709A1 (en) Pyrimidine derivatives and their use for preventing and treating cerebral ischaemia
PL361947A1 (en) Amidoalkyl-piperidine and amidoalkyl-piperazine derivatives for treating of nervous systems disorders
SI1176964T1 (sl) Uporaba et743 za zdravljenje raka
IL145701A0 (en) Purine derivatives having phosphodiesterase iv inhibition activity
EP1194147A4 (en) DERIVATIVES OF ARYLTHIAZOLIDINEDIONE AND ARYLOXAZOLIDINEDIONE
HU0003409D0 (en) Treatment or prevention of coccidiosis
PL352409A1 (en) Derivatives of 1-trifluorometyl-4-hydroxy-7-piperidinyl-aminomethylochromane
GB9921958D0 (en) Formulations for parenteral use of estramustine phosphate and sulfoalkylether-cyclodextrins
HUP0202645A3 (en) Fornulations for parenteral use of estramustine phosphate and albumin
AU2001276375A1 (en) Bicyclic lactams and sulfonamides with 5-ht1a-affinity and use thereof for preventing and treating cerebral ischaemia
AU5038499A (en) Use of xanthine derivatives for treating erectile disorder
GB9926359D0 (en) Treatment of alopecia
TW395176U (en) Structure of designed article
GB9911183D0 (en) Treatment of cancers
GB9818295D0 (en) Treatment of alopecia
GB9916166D0 (en) Security printing of articles
TW407494U (en) Structural improvement of medial bed